Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Admission today to trading on Euronext Growth

Immupharma PLC - Publication of Information Note (Euronext Growth)

Immupharma PLC - Dual Listing on Euronext Growth Brussels

Immupharma PLC - Share Price Volatility

Immupharma PLC - IMMUPHARMA TO PRESENT AT BIOTECH SHOWCASET 2020

Immupharma PLC - TR-1: notification of major holdings

Immupharma PLC - Licence Agreement for Lupuzor with Avion in US

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Interim Results Announcement

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - TR-1: notification of major holdings

Immupharma PLC - TR-1: notification of major holdings

Immupharma PLC - TR-1: notification of major holdings

Immupharma PLC - Update on Lupuzor

Immupharma PLC - 2019 Annual General Meeting

Immupharma PLC - Subscription to raise £2.66 million

Immupharma PLC - Notice of AGM and posting of Report & Accounts

Immupharma PLC - FINAL RESULTS

Immupharma PLC - Corporate Update - Replacement

Immupharma PLC - Corporate Update - Replacement

Immupharma PLC - Corporate Update

Immupharma PLC - Update on Nucant Cancer Programme

Immupharma PLC - Corporate Update

Immupharma PLC - Technology review published-Nature Communications

Immupharma PLC - Clinical Development Collaboration with Incanthera

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Appointment of Nominated Adviser

Immupharma PLC - Update on Corporate Activities

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Nominated Adviser Status

Immupharma PLC - Interim Results

Immupharma PLC - Appointment of Joint Brokers

Immupharma PLC - Corporate Update

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Result of AGM

Immupharma PLC - Results of CIDP Pre-Clinical Data

Immupharma PLC - Notice of AGM & Posting of Annual Report

Immupharma PLC - Final Results

Immupharma PLC - Update on Pivotal Phase III Trial of Lupuzor

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Topline results of Lupuzor Pivotal Phase III Trial

Immupharma PLC - Appointment of Joint Broker

Immupharma PLC - Lupuzor Pivotal Phase III Study Update

Immupharma PLC - AIM Notice (17)

Immupharma PLC - Grant of Options

Immupharma PLC - Last patient completes dosing in LupuzorT Trial

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Grant of Options

Immupharma PLC - Update on LupuzorT Pivotal Phase III Study

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Completion of Lanstead Sharing Agreement

Immupharma PLC - Interim Results

Immupharma PLC - Preparation of Lupuzor'sT Regulatory Submissions

Immupharma PLC - Update on LupuzorT Pivotal Phase III Study

Immupharma PLC - Notification of Interim Results

Immupharma PLC - AIM Rule 17 Notice

Immupharma PLC - Grant of Options

Immupharma PLC - Result of AGM

Immupharma PLC - Update on LupuzorT Pivotal Phase III Study

Immupharma PLC - Annual Report & Notice of AGM

Immupharma PLC - Final Results

Immupharma PLC - Notification of Full Year Results

Immupharma PLC - Update on Lupuzor Phase III Study

Immupharma PLC - New Employee Share Option Plan & Grant of Options

Immupharma PLC - New Employee Share Option Plan & Grant of Options

Immupharma PLC - ImmuPharma to present at Master Investor Show

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - £4.1 Million Fund Raise via Accelerated Bookbuild

Immupharma PLC - Accelerated Bookbuild for the Issue of Equity

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Update on Lupuzor Phase III Study

Immupharma PLC - Change of Adviser

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Update on Lupuzor Pivotal Phase III Study

Immupharma PLC - Update on Cancer Compound IPP-204106 'Nucant'

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Close of Accelerated Bookbuild

Immupharma PLC - Proposed Accelerated Bookbuild for Vendor Placing

Immupharma PLC - Half-year Report

Immupharma PLC - UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY

Immupharma PLC - UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Second Price Monitoring Extn

Immupharma PLC - Price Monitoring Extension

Immupharma PLC - Appointment of Joint Broker

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Symposium with Lupuzors Inventor Prof. S Muller

Immupharma PLC - European Patients Commence Dosing in Lupuzor

Immupharma PLC - Director/PDMR Shareholding

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Result of AGM

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Annual Financial Report & Notice of AGM

Immupharma PLC - Final Results

Immupharma PLC - Notice of Results

Immupharma PLC - Holding(s) in Company

Immupharma PLC - First European Site Opens - Patient Recruitment

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Holding(s) in Company

Immupharma PLC - EIS and VCT Qualifying Status and Issue of Equity

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Issue of Equity

Immupharma PLC - Result of GM

Immupharma PLC - US PATIENTS COMMENCE DOSING IN PHASE III STUDY

Immupharma PLC - Placing and Subscription Raises £8.3 million

Immupharma PLC - Proposed Placing and Subscription

Immupharma PLC - Holding(s) in Company

Immupharma PLC - ImmuPharma & Simbec-Orion - Investigators Meeting

Immupharma PLC - Update on the progress of Lupuzor

Immupharma PLC - Holding(s) in Company

Immupharma PLC - Lupuzor Phase III Pivotal Trial Update

Immupharma PLC - Lupuzor Phase III Pivotal Trial Update

Immupharma PLC - Directorate Change

Immupharma PLC - Directorate Change

Immupharma PLC - Interim Results

Immupharma PLC - Richard Warr

Immupharma PLC - TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR

Immupharma PLC - Lupuzor's Founder Dr Slyviane Muller Awarded Medal

Immupharma PLC - Result of AGM

Immupharma PLC - Annual Report & Accounts

Immupharma PLC - Interim Board Change

Immupharma PLC - Directorate Change

Immupharma PLC - Preliminary Results

Immupharma PLC - Enterprise Investment Scheme Status